NEW YORK, Jan. 31 /PRNewswire/ -- QED International Associates, Inc., administrator for the HealthShares(TM) Indexes, a series of 20 underlying indexes for the HealthShares(TM) Exchange-Traded Funds, today announced that effective at the opening of trading on Monday February 4, 2008, BioMerieux Worldwide (Euronext: BIM) will replace GYRUS GROUP PLC (GYG LN) in the HealthShares(TM) European Medical Products and Devices Index.
Companies that are included in The HealthShares(TM) European Medical Products and Devices Index are headquartered in Europe, quoted on at least one European Stock Exchange and are engaged in the research, development, manufacturing, distribution and/or commercialization of medical devices and/or products for the treatment or amelioration of human disorders and diseases.
About QED International Associates
QED International, based in New York, is a leading financial industry consulting firm specializing in quantitative modeling and the design, development and maintenance of indexes and Exchange Traded Funds. For more information, visit the company's website at http://www.qedinternational.com.
|SOURCE QED International Associates, Inc.|
Copyright©2008 PR Newswire.
All rights reserved